BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
+12.1%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$12.3B
AUM Growth
+$12.3B
Cap. Flow
+$170M
Cap. Flow %
1.38%
Top 10 Hldgs %
85.9%
Holding
130
New
9
Increased
24
Reduced
9
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAB icon
76
AnaptysBio
ANAB
$594M
$3.89M 0.03%
111,386
-5,825
-5% -$204K
ADMS
77
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
$3.66M 0.03%
172,630
ARAV
78
DELISTED
Aravive, Inc. Common Stock
ARAV
$3.52M 0.03%
1,437,214
-223,379
-13% -$547K
TNXP icon
79
Tonix Pharmaceuticals
TNXP
$246M
$3.19M 0.03%
699,500
+188,578
+37% +$860K
AKTX
80
Akari Therapeutics
AKTX
$21.2M
$3.05M 0.02%
496,901
NTRA icon
81
Natera
NTRA
$23.3B
$2.95M 0.02%
228,676
OVID icon
82
Ovid Therapeutics
OVID
$90.3M
$2.86M 0.02%
333,333
MDGL icon
83
Madrigal Pharmaceuticals
MDGL
$9.56B
$2.6M 0.02%
57,762
RARX
84
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$2.6M 0.02%
177,952
TRVN
85
DELISTED
Trevena, Inc.
TRVN
$2.42M 0.02%
950,000
KPTI icon
86
Karyopharm Therapeutics
KPTI
$59.9M
$2.38M 0.02%
216,990
NVAX icon
87
Novavax
NVAX
$1.24B
$2.28M 0.02%
2,000,000
ARGX icon
88
argenx
ARGX
$43.7B
$2.26M 0.02%
100,000
TRIL
89
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.13M 0.02%
413,697
KRYS icon
90
Krystal Biotech
KRYS
$4.36B
$1.99M 0.02%
+200,000
New +$1.99M
DVAX icon
91
Dynavax Technologies
DVAX
$1.18B
$1.61M 0.01%
75,000
JNCE
92
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.56M 0.01%
100,000
IMDZ
93
DELISTED
Immune Design Corp.
IMDZ
$1.54M 0.01%
148,937
VIRX
94
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$1.44M 0.01%
741,665
CLLS
95
Cellectis
CLLS
$265M
$1.42M 0.01%
50,000
MDWD icon
96
MediWound
MDWD
$180M
$1.21M 0.01%
226,000
ABUS icon
97
Arbutus Biopharma
ABUS
$759M
$1.12M 0.01%
180,582
QLGN icon
98
Qualigen Therapeutics
QLGN
$3.03M
$980K 0.01%
2,800,000
+2,400,000
+600% +$840K
AFMD
99
DELISTED
Affimed
AFMD
$900K 0.01%
400,000
ADAP
100
Adaptimmune Therapeutics
ADAP
$14.7M
$819K 0.01%
100,000